Literature DB >> 16879785

Assessment of islet function following islet and pancreas transplantation.

Emily C Dy1, David M Harlan, Kristina I Rother.   

Abstract

Pancreas and islet transplant recipients are monitored using various metabolic and imaging methods. The inaccessibility of the transplanted whole pancreas and of the isolated islets poses specific problems (eg, all assessment techniques are indirect). Although successful pancreas transplantation typically restores normal glucose homeostasis, islet transplantation into the liver does not completely normalize islet hormone secretion and glucose metabolism. Development of better testing strategies, such as direct islet imaging, will significantly advance the field.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16879785      PMCID: PMC4143982          DOI: 10.1007/s11892-006-0067-y

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  53 in total

1.  Continuous measurement of oxygen consumption by pancreatic islets.

Authors:  Ian R Sweet; Gamal Khalil; Angela R Wallen; Mark Steedman; Kenneth A Schenkman; Jo Anna Reems; Steven E Kahn; James B Callis
Journal:  Diabetes Technol Ther       Date:  2002       Impact factor: 6.118

2.  Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppression.

Authors:  Boaz Hirshberg; Steven Mog; Noelle Patterson; John Leconte; David M Harlan
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

3.  Technical and immunologic progress in simultaneous pancreas-kidney transplantation.

Authors:  Dixon B Kaufman; Joseph R Leventhal; Lorenzo G Gallon; Michele A Parker; Michael D Elliott; Mihai Gheorghiade; Alan J Koffron; Jonathan P Fryer; Michael M Abecassis; Frank P Stuart
Journal:  Surgery       Date:  2002-10       Impact factor: 3.982

4.  Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic patients.

Authors:  L Luzi; G Perseghin; M D Brendel; I Terruzzi; A Battezzati; M Eckhard; D Brandhorst; H Brandhorst; S Friemann; C Socci; V Di Carlo; L Piceni Sereni; S Benedini; A Secchi; G Pozza; R G Bretzel
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

5.  Pancreas transplantation for patients with type 1 diabetes.

Authors:  R Paul Robertson; Connie Davis; Jennifer Larsen; Robert Stratta; David E R Sutherland
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

Review 6.  Lessons learned from more than 1,000 pancreas transplants at a single institution.

Authors:  D E Sutherland; R W Gruessner; D L Dunn; A J Matas; A Humar; R Kandaswamy; S M Mauer; W R Kennedy; F C Goetz; R P Robertson; A C Gruessner; J S Najarian
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

7.  Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients.

Authors:  M Boratyńska; M Banasik; E Watorek; K Falkiewicz; D Patrzałek; P Szyber; M Klinger
Journal:  Transplant Proc       Date:  2006 Jan-Feb       Impact factor: 1.066

8.  Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence.

Authors:  Breay W Paty; Edmond A Ryan; A M James Shapiro; Jonathan R T Lakey; R Paul Robertson
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

9.  Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations.

Authors:  J Oberholzer; F Triponez; R Mage; E Andereggen; L Bühler; N Crétin; B Fournier; C Goumaz; J Lou; J Philippe; P Morel
Journal:  Transplantation       Date:  2000-03-27       Impact factor: 4.939

10.  Successful islet transplantation: continued insulin reserve provides long-term glycemic control.

Authors:  Edmond A Ryan; Jonathan R T Lakey; Breay W Paty; Sharleen Imes; Gregory S Korbutt; Norman M Kneteman; David Bigam; Ray V Rajotte; A M James Shapiro
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

View more
  2 in total

1.  Implanted islets in the anterior chamber of the eye are prone to autoimmune attack in a mouse model of diabetes.

Authors:  Majid Mojibian; Brigitte Harder; Andrew Hurlburt; Jennifer E Bruin; Ali Asadi; Timothy J Kieffer
Journal:  Diabetologia       Date:  2013-08-11       Impact factor: 10.122

2.  Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.

Authors:  Kristina I Rother; Lisa M Spain; Robert A Wesley; Benigno J Digon; Alain Baron; Kim Chen; Patric Nelson; H-Michael Dosch; Jerry P Palmer; Barbara Brooks-Worrell; Michael Ring; David M Harlan
Journal:  Diabetes Care       Date:  2009-10-06       Impact factor: 19.112

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.